股票代码
000661
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
CN
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
To stimulate the potential of life so that life blossomed in the hone
Investor
Periodical report
Company announcement
Interactive platform
CN
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Home
About
Group introduction
Leading teams
Organizational chart
Enterprise culture
Development strategy
Honor qualification
Investment enterprise
Business
Pharmaceutical industry
Real-estate development
Innovation
News
Investor
Stock information
Company governance
Periodical report
Company announcement
Interactive platform
Talent
Talent concept
Talent recruitment
Talent cultivation
CSR
Concept of responsibility
Public welfare
Total
2,137
announcements
关于子公司全人源抗破伤风毒素单克隆抗体A82/B86注射液组合制剂临床试验申请获得批准的公告
2023-11-01
关于子公司相关权益产品利斯的明透皮贴剂(一周两次)在中国获批上市的公告
2023-11-01
关于控股子公司外用人粒细胞巨噬细胞刺激因子凝胶补充申请获得批准的公告
2023-10-31
关于首次回购公司股份暨回购结果与股份变动的公告
2023-10-30
关于子公司投资建设项目的提示性公告
2023-10-24
2023年三季度报告
2023-10-24
关于股份回购进展情况的公告
2023-10-10
关于控股子公司百克生物披露2023年第三季度业绩预告的提示性公告
2023-09-28
关于第一大股东部分股份解除质押及再质押的公告
2023-09-27
关于竞拍取得国有土地使用权的公告
2023-09-27
关于回购股份事项前十名股东和前十名无限售条件股东持股情况的公告
2023-09-08
回购报告书
2023-09-08
关于公司回购股份方案的公告
2023-09-02
第十届董事会第二十八次会议决议公告
2023-09-02
独立董事关于第十届董事会第二十八次会议相关事项的独立意见
2023-09-02
上一页
14
15
16
17
18
19
20
21
22
23
24
下一页